MedTrace Logo

12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

NCT04724577 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-11-19

No results posted yet for this study

Summary

The arm of this study is to explore the optimal dose of 12 fractions of carbon ion radiotherapy for prostate cancer in our center.

Conditions

Interventions

RADIATION

carbon ion radiotherapy

dose escalation radiotherapy with five levels of dose from 54GyE/12Fx to 58.8GyE/12Fx

Sponsors & Collaborators

  • Shanghai Proton and Heavy Ion Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2022-12-01
Completion
2023-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724577 on ClinicalTrials.gov